As aging bodies decline, the brain loses the ability to cleanse itself of waste, a scenario that scientists think could be contributing to neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease, among others. Now, researchers at Washington University School of Medicine in St. Louis report they have found a way around that problem by … Read more
New research highlights the global impact of insufficient omega-3 consumption on ischemic heart disease disability and mortality, with regional and socioeconomic disparities shaping risk levels. Study: A global analysis of the burden of ischemic heart disease attributable to diet low in ω-3 fatty acids between 1990 and 2021. Image Credit: artem evdokimov / Shutterstock.com A recent … Read more
An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis. The … Read more
Archyde Curcumin and Bedaquiline: A Novel Combination Therapy Against Drug-Resistant Infections Table of Contents 1. Curcumin and Bedaquiline: A Novel Combination Therapy Against Drug-Resistant Infections 2. Fighting Back Against Antibiotic Resistance: A New Hope? 3. the Power of Synergy: Curcumin and Bedaquiline 4. Real-World Implications and Future Directions 5. Addressing Potential Counterarguments 6. Looking Ahead: … Read more
Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have respiratory conditions or are immunocompromised face a higher risk. It can also cause skin infections. The microbe is closely related to the one that causes tuberculosis and is naturally resistant to many antibiotics. Infections often require a year or … Read more
A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT (Aspirin after completion of standard adjuvant therapy for colorectal cancer) trial is the first phase 3 study to assess the efficacy and safety of aspirin in preventing the recurrence of … Read more
“`html Aspirin’s Evolving Role in Colorectal Cancer Prevention: New Hope for Targeted Treatment Published: 2025-03-17 | World-Today-News.com Recent studies, including the ASCOLT and ALASCCA trials, are reshaping our understanding of aspirin’s potential in preventing colorectal cancer recurrence. while aspirin doesn’t offer a global benefit, research suggests it could be a powerful tool for specific patient … Read more
Why are some children devastated by mysterious post-COVID inflammation? Scientists uncover how a ‘silent’ virus awakens – and a promising path to stop it. Study: TGFβ links EBV to multisystem inflammatory syndrome in children. Image Credit: Kateryna Kon / Shutterstock A new study published in the journal Nature reveals a potential mechanism associated with the development of … Read more
Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. The main findings from this randomized controlled trial that enrolled persons who inject drugs showed that similar numbers of participants were on medication for opioid use … Read more
Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma. Among these, thymic carcinoma is the more aggressive subtype, characterized by high invasiveness, metastatic potential, and poor prognosis. With an incidence of just 0.15 cases per 100,000 person-years, its rarity poses significant challenges for treatment … Read more